Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $604.9000 (-2.24%) ($603.6600 - $604.9000) on Tue. Sep. 28, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.49% (three month average) | RSI | 25 | Latest Price | $604.9000(-2.24%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.1% a day on average for past five trading days. | Weekly Trend | REGN declines -1.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(54%) XLV(41%) DIA(38%) IWD(37%) SPY(36%) | Factors Impacting REGN price | REGN will decline at least -0.745% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) VXX(-5%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.745% (StdDev 1.49%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $652.19 | 5 Day Moving Average | $631.76(-4.25%) | 10 Day Moving Average | $639.25(-5.37%) | 20 Day Moving Average | $652.19(-7.25%) | To recent high | -11.6% | To recent low | 11.5% | Market Cap | $64.137b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |